{"id":57854,"date":"2024-02-27T18:04:28","date_gmt":"2024-02-27T18:04:28","guid":{"rendered":"https:\/\/medsname.com\/ketanov-injection\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"ketanov-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/ketanov-injection\/","title":{"rendered":"Ketanov-injeksjon"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Ketanov Injection?<\/h3>\n<p style=\"margin:0;\"><strong>Ketanov-injeksjon<\/strong> er en <strong>ketorolac tromethamine 30&nbsp;mg\/ml ampoule<\/strong> i <strong>intramuskul\u00e6r eller intraven\u00f8s<\/strong> administration. It is one of the most potent parenteral NSAIDs available and is used in emergency rooms, day-case surgery, and post-operative recovery for <strong>moderate to severe acute pain<\/strong>. Standarddose for voksne er <strong>30&nbsp;mg IM every 6 hours<\/strong> (maximum 120&nbsp;mg\/day for \u2264 2 days parenteral, \u2264 5 days total including any oral ketorolac). It is <strong>ikke<\/strong> used chronically.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hva du f\u00e5r med MedsBase:<\/strong> WHO-GMP-sertifisert produsent \u00b7 Diskret emballasje \u00b7 Verdensomspennende levering \u00b7 1 400+ verifiserte <a href=\"https:\/\/medsbase.com\/nb\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er dekket av v\u00e5r <a href=\"https:\/\/medsbase.com\/nb\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n<p><strong>Ketanov-injeksjon<\/strong> is an ampoule of <strong>ketorolac tromethamine 30&nbsp;mg\/ml<\/strong>, manufactured by Cipla. Ketorolac injection is used in acute-care settings where strong, fast, non-opioid pain control is needed &mdash; emergency rooms for renal colic and major trauma, post-operative recovery areas, day-case surgery units, and peri-operative pain protocols that aim to reduce opioid requirement.<\/p>\n<p>Ketorolac&#8217;s parenteral analgesic potency is comparable to low-dose morphine: 30&nbsp;mg IM ketorolac is broadly equivalent to 6&ndash;12&nbsp;mg IM morphine for moderate post-operative pain, without the sedation, respiratory depression, or abuse potential.<\/p>\n<h2 class=\"wp-block-heading\">What Is Ketanov Injection Used For?<\/h2>\n<ul>\n<li><strong>Postoperativ smerte<\/strong> &mdash; particularly in day-case surgery and orthopaedic procedures; often combined with paracetamol for an &ldquo;opioid-sparing&rdquo; regimen<\/li>\n<li><strong>Nyresmerter<\/strong> &mdash; kidney-stone pain; parenteral ketorolac is a first-line agent in many ED protocols<\/li>\n<li><strong>Biliary colic<\/strong><\/li>\n<li><strong>Acute musculoskeletal trauma<\/strong> &mdash; fractures before definitive treatment, severe soft-tissue injury<\/li>\n<li><strong>Severe acute migraine<\/strong> &mdash; when oral therapy fails or vomiting precludes oral dosing<\/li>\n<li><strong>Severe dysmenorrhoea<\/strong> &mdash; when oral NSAID is not tolerated<\/li>\n<li><strong>Acute-on-chronic cancer pain<\/strong> &mdash; short-term adjunct to opioid therapy under specialist supervision<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">How Does Ketorolac Work?<\/h2>\n<p>Ketorolac is a <strong>ikke-selektivt NSAID<\/strong> \u2014 det blokkerer b\u00e5de <strong>COX-1<\/strong> (som opprettholder mageslimhinnen, blodplatenes funksjon og nyreperfusjon) og <strong>COX-2<\/strong> (som er oppregulert ved inflammasjonssteder). Denne brede virkningen forklarer b\u00e5de dens sterke antiinflammatoriske effekt og dens velkjente bivirkningsprofil i mage-tarmkanalen og nyrene.<\/p>\n<p>Den terapeutiske hendelseskjeden er den samme for alle NSAID-er:<\/p>\n<ol>\n<li>Vevsskade eller betennelse frigj\u00f8r fosfolipider fra cellemembraner<\/li>\n<li>Fosfolipase A\u2082 omdanner dem til arakidonsyre<\/li>\n<li>Syklooksygenase (COX-1\/COX-2) omdanner arakidonsyre til <strong>prostaglandiner<\/strong> \u2014 molekylene som er ansvarlige for smerte, hevelse og feber<\/li>\n<li>Ketorolac blocks the COX enzymes, so less prostaglandin is produced, so there is less pain and inflammation<\/li>\n<\/ol>\n<p>Siden prostaglandiner ogs\u00e5 beskytter mageslimhinnen, regulerer nyreblodstr\u00f8mmen og p\u00e5virker blodplatefunksjonen, er den samme mekanismen som lindrer smerte ogs\u00e5 ansvarlig for hovedbivirkningene ved NSAID-er: mageirritasjon, v\u00e6skeansamling, h\u00f8yt blodtrykk og (hos enkelte) nyrebelastning.<\/p>\n<h2 class=\"wp-block-heading\">Ketanov Injection Dosing<\/h2>\n<ul>\n<li><strong>Adult (&gt; 50 kg, under 65):<\/strong> 30&nbsp;mg IM or slow IV every 6 hours; maximum 120&nbsp;mg\/day<\/li>\n<li><strong>Elderly (&gt; 65), body weight &lt; 50 kg, mild renal impairment:<\/strong> 15&nbsp;mg every 6 hours; maximum 60&nbsp;mg\/day<\/li>\n<li><strong>Single-dose IM:<\/strong> 60&nbsp;mg (under 65, normal weight) or 30&nbsp;mg (elderly, low weight)<\/li>\n<li><strong>Single-dose IV:<\/strong> 30&nbsp;mg slow IV push over at least 15 seconds<\/li>\n<li><strong>Maximum parenteral duration:<\/strong> 2 dager<\/li>\n<li><strong>Maximum total (parenteral + oral) duration:<\/strong> 5 dager<\/li>\n<\/ul>\n<p>The injection is given by a healthcare professional. Self-administration is not appropriate for ketorolac.<\/p>\n<p>When transitioning from injection to oral: first oral dose is given at the time the next parenteral dose would have been due. Total combined therapy still must not exceed 5 days.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:16px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>GI-sikkerhet \u2014 les dette f\u00f8r f\u00f8rste dose.<\/strong> Every NSAID, including Ketanov Injection, carries a real risk of gastritis, peptic ulcer, and upper-GI bleeding. The risk is highest in patients over 65, in those with prior ulcer disease, and in anyone also taking low-dose aspirin, corticosteroids, SSRIs, or anticoagulants. Take Ketanov Injection <em>med mat<\/em>, bruk den <em>laveste effektive dosen i kortest mulig tid<\/em>, og sp\u00f8r legen din om samtidig forskrivning av en protonpumpehemmer (omeprazol, pantoprazol) hvis du trenger det i mer enn 2\u20134 uker.<\/p>\n<\/div>\n<h2 class=\"wp-block-heading\">Who Should Not Receive Ketanov Injection?<\/h2>\n<ul>\n<li>Known hypersensitivity to Ketorolac or any NSAID<\/li>\n<li>Aktivt eller tilbakevendende mages\u00e5r, mage-tarmbl\u00f8dning eller perforasjon i mage-tarmkanalen<\/li>\n<li>Astma, utslett eller nesebetennelse utl\u00f8st av aspirin eller annen NSAID (\u201caspirin-forverret luftveissykdom\u201d)<\/li>\n<li>Alvorlig hjertesvikt (NYHA klasse IV)<\/li>\n<li>Alvorlig leverfunksjonssvikt (Child\u2013Pugh C)<\/li>\n<li>Alvorlig nyresvikt (CrCl &lt; 30 ml\/min)<\/li>\n<li>Tredje trimester av graviditet (risiko for tidlig lukking av ductus arteriosus og oligohydramnion)<\/li>\n<li>Nylig bypassoperasjon (CABG) \u2014 absolutt kontraindikasjon for alle NSAID-er<\/li>\n<\/ul>\n<p><strong>Parenteral ketorolac-specific:<\/strong><\/p>\n<ul>\n<li>Suspected or actual cerebrovascular bleeding, intracranial surgery, or bleeding diathesis<\/li>\n<li>Incomplete haemostasis or high bleeding risk (e.g. on anticoagulants)<\/li>\n<li>Neuraxial (spinal\/epidural) administration &mdash; formulation is not intended for this route<\/li>\n<li>Labour and delivery<\/li>\n<li>Severe volume depletion &mdash; rehydrate first<\/li>\n<li>Children &lt; 16 years in most jurisdictions<\/li>\n<li>Prophylaxis before major surgery with high bleeding risk<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Kardiovaskul\u00e6r risiko<\/h3>\n<p>Alle NSAID-er (unntatt lavdose aspirin) medf\u00f8rer en viss \u00f8kning i risiko for hjerteinfarkt og slag, og kan forverre hjertesvikt. Risikoen er dose- og varighetsavhengig og er generelt h\u00f8yest med COX-2-selektive midler og med diklofenak. Pasienter med etablert iskemisk hjertesykdom, perifer arteriell sykdom, slag, eller ukontrollert hypertensjon b\u00f8r bruke ikke-selektive NSAID-er (ibuprofen eller naproxen) i lavest mulig effektiv dose, eller bruke paracetamol der det er mulig.<\/p>\n<h3 class=\"wp-block-heading\">Nyresikkerhet<\/h3>\n<p>NSAID-er reduserer produksjonen av nyreprostaglandiner, noe som kan f\u00f8re til salt- og vannretensjon, \u00f8kt blodtrykk, og \u2013 hos s\u00e5rbare pasienter \u2013 akutt nyreskade. H\u00f8yrisikogrupper er eldre, pasienter p\u00e5 ACE-hemmere\/ARB-er pluss diuretika (den \u201ctriple whammy\u201d), alle med dehydrering (kvalme, diar\u00e9, varme, tung trening), og de med allerede eksisterende kronisk nyresykdom (CKD). Stopp NSAID og s\u00f8k legehjelp hvis du utvikler redusert urinproduksjon, hevelser eller uforklarlig vekt\u00f8kning.<\/p>\n<h2 class=\"wp-block-heading\">Side Effects of Ketanov Injection<\/h2>\n<ul>\n<li><strong>Vanlig:<\/strong> pain at the IM injection site, nausea, dyspepsia, drowsiness, dizziness, sweating, headache<\/li>\n<li><strong>Sjeldne, men viktige:<\/strong> peptic ulcer and GI bleeding, acute kidney injury (especially in volume-depleted or elderly patients), hypertension, post-operative wound bleeding, elevated liver enzymes<\/li>\n<li><strong>Sjeldne:<\/strong> anaphylaxis, severe hepatotoxicity, Stevens-Johnson syndrome, bronchospasm, aseptic meningitis<\/li>\n<\/ul>\n<p>Seek urgent review for: signs of GI bleeding, breathing difficulty, facial swelling, severe wound bleeding after surgery, reduced urine output, or a widespread rash.<\/p>\n<h2 class=\"wp-block-heading\">Bestilling og levering<\/h2>\n<p>MedsBase tilbyr verdensomspennende frakt p\u00e5 alle bestillinger. Bestillinger sendes i diskrete emballasjer og ankommer i merkevareprodusentens pakninger. Hvis din foretrukne styrke eller pakkest\u00f8rrelse er utsolgt, ta kontakt med kundeservice for en estimert leveringstid.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:20px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>Medisinsk ansvarsfraskrivelse.<\/strong> Informasjonen p\u00e5 denne siden er kun til generell opplysning. Den er ikke erstatning for r\u00e5d fra din egen lege eller apotek. NSAID-er har veldokumenterte risikoer for mage-tarm, hjerte-kar og nyre \u2013 vennligst snakk med en kvalifisert helsepersonell f\u00f8r du starter, stopper eller endrer behandling, spesielt hvis du har historie med mages\u00e5r, hjertesykdom, nyresykdom, astma, eller er gravid.<\/p>\n<\/div>\n<h2 id=\"faqs\">Vanlige sp\u00f8rsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">What is Ketanov Injection used for?<\/h3>\n<p>Ketanov Injection (ketorolac 30&nbsp;mg\/ml) is used for short-term treatment of moderate to severe acute pain &mdash; post-operative, renal colic, biliary colic, acute trauma, severe migraine, and severe dysmenorrhoea.<\/p>\n<h3 class=\"wp-block-heading\">How is Ketanov Injection different from Ketorol DT?<\/h3>\n<p>Same molecule (ketorolac). Ketanov is the 30&nbsp;mg\/ml IM\/IV injection used in emergency rooms and post-operative care; Ketorol DT is the 10&nbsp;mg oral disintegrating tablet for step-down or home use. Total combined therapy must stay within 5 days.<\/p>\n<h3 class=\"wp-block-heading\">How fast does Ketanov Injection work?<\/h3>\n<p>Onset is 10&ndash;30 minutes IM and within minutes IV. Peak effect at 45&ndash;60 minutes IM; duration 4&ndash;6 hours per dose.<\/p>\n<h3 class=\"wp-block-heading\">Is Ketanov Injection as strong as morphine?<\/h3>\n<p>For moderate post-operative pain, 30&nbsp;mg IM ketorolac is comparable to 6&ndash;12&nbsp;mg IM morphine in most studies, without sedation, respiratory depression, or addiction risk. Many hospitals use ketorolac as part of an opioid-sparing regimen.<\/p>\n<h3 class=\"wp-block-heading\">Can I give Ketanov Injection at home?<\/h3>\n<p>No. Ketanov is an IM\/IV injection that should be given by a trained healthcare professional. Self-administration is not appropriate because of bleeding risk, potential injection-site problems, and the need for clinical monitoring.<\/p>\n<h3 class=\"wp-block-heading\">Why can&#8217;t I have ketorolac for more than 5 days?<\/h3>\n<p>The risk of GI ulcer, GI bleeding, and acute kidney injury rises sharply beyond 5 days of continuous ketorolac therapy. This is a regulatory and clinical limit. After 5 days, your pain should be managed with other NSAIDs, paracetamol, or &mdash; if truly necessary &mdash; opioids, under medical supervision.<\/p>\n<h3 class=\"wp-block-heading\">Can Ketanov Injection be combined with paracetamol?<\/h3>\n<p>Yes &mdash; this combination is standard peri-operative care. Paracetamol 1&nbsp;g IV or oral plus ketorolac 30&nbsp;mg IM gives additive, multimodal pain relief.<\/p>\n<h3 class=\"wp-block-heading\">Can Ketanov Injection be given before surgery?<\/h3>\n<p>Usually not as a pre-emptive analgesic in procedures with high bleeding risk. In lower-bleeding-risk surgery, an intra-operative dose is sometimes used under the surgeon&#8217;s judgement.<\/p>\n<h3 class=\"wp-block-heading\">Is Ketanov Injection safe in elderly patients?<\/h3>\n<p>Use a reduced dose (15&nbsp;mg every 6 hours, maximum 60&nbsp;mg\/day) and the shortest possible duration. Elderly patients are particularly at risk of GI and renal side effects.<\/p>\n<h3 class=\"wp-block-heading\">Does Ketanov Injection cause drowsiness or sedation?<\/h3>\n<p>Mild drowsiness is possible, but ketorolac does not cause the heavy sedation seen with opioids.<\/p>\n<h3 class=\"wp-block-heading\">Is Ketanov Injection safe in pregnancy?<\/h3>\n<p>No &mdash; ketorolac is contraindicated during labour and delivery and should be avoided from 20 weeks of pregnancy onward. Paracetamol or morphine-equivalent analgesia is preferred.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterte alternativer<\/h3>\n<p>Andre produkter innen <strong>Kroniske tilstander<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nb\/cort-s-injection\/\">Cort-S Injection<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/syndopa\/\">Syndopa<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/glinil-m\/\">Glinil M<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/azoran\/\">Azoran<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/efavir\/\">Efavir<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Rask smertelindring<br \/>\n\u2705 Powerful anti-inflammatory<br \/>\n\u2705 Injectable convenience<br \/>\n\u2705 Effective post-surgery<br \/>\n\u2705 Analgesic action<\/p>\n<p>Ketanov Injection contains Ketorolac.<\/p>","protected":false},"featured_media":57855,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3555],"product_tag":[4371,4370],"class_list":{"0":"post-57854","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-pain-relief-medication","9":"product_tag-ketanov-injection","10":"product_tag-ketorolac","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/57854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=57854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/57855"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=57854"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=57854"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=57854"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=57854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}